InvestorsHub Logo
Followers 35
Posts 4637
Boards Moderated 0
Alias Born 03/18/2013

Re: None

Thursday, 03/07/2024 9:03:07 AM

Thursday, March 07, 2024 9:03:07 AM

Post# of 183484
MindMed’s stock jumps 24% after FDA grants breakthrough designation

MindMed’s stock jumps 24% after FDA grants breakthrough designation to LSD therapy for a form of anxiety

By Ciara LinnaneFollow

Biotech also issues new shares and reports positive data from Phase 2b trial

Mind Medicine Inc.’s stock jumped 24% early Thursday, after the biotech company said the Food and Drug Administration has granted breakthrough designation for its MM120 LSD-based treatment for generalized anxiety disorder.
Published: March 7, 2024 at 8:26 a.m. ET